Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Crescent Energy Co files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
1,087
754
1,477
3,057
2,383
2,931
3,580
General and administrative
2.36
16.5
78.3
85
141
336
472
Operating expenses
860
1,128
993
1,773
2,058
2,712
3,351
Operating income
227
-374
484
1,284
325
218
229
Interest expense
53.6
38.1
50.7
95.9
146
216
298
Other non-operating income
-180
158
-916
-767
20.5
-387
-27.6
Pre-tax income
46.7
-216
-433
517
345
-169
202
Income tax
0.03
0.01
-0.31
36.3
23.2
-31.1
34.5
Net income
0
0
-19.4
96.7
67.6
-115
133
EBITDA
538
-1.33
797
1,817
1,001
1,168
1,396
Balance sheet
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
19.9
36.9
129
0
2.97
133
10.2
Receivables
112
322
457
Other current assets
1.95
8.64
28.9
11
11.6
13.3
Total current assets
220
480
517
616
788
1,861
Property, plant and equipment
3,642
4,555
5,438
6,116
8,145
10,276
Lease right-of-use assets
2.3
5
24.2
66.6
81.3
Goodwill
0
76.6
0
0
Other non-current assets
22.4
30.2
50.3
57.7
207
151
Total assets
3,907
5,157
6,020
6,803
9,161
12,443
Accounts payable
15
87.3
104
125
Total current liabilities
121
616
894
750
827
1,259
Long-term debt
751
1,030
1,248
1,694
3,049
5,524
Lease liabilities
1.01
Other non-current liabilities
12.1
13.7
14.2
35
55.5
82.8
Total liabilities
1,014
2,138
2,721
3,168
4,793
7,278
Total debt
751
1,030
1,248
1,694
3,049
5,524
Paid-in capital
720
805
1,627
3,227
5,229
Retained earnings
-19.4
62
95.4
-64.8
0
Treasury stock
-18.4
-18.4
-17.1
-32.4
-71.1
Minority interests
12.4
14.2
29.7
9.34
7.53
Total equity
695
862
1,735
3,140
5,165
Total liabilities and equity
3,907
5,157
6,020
6,803
9,161
12,443
Cash flow statement
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
46.7
-216
-432
481
322
-138
167
Depreciation and amortization
311
372
313
533
676
949
1,167
Stock-based compensation
-2.72
-0.8
39.9
38.1
82.9
186
245
Deferred income tax
0
0
-0.94
33.2
22.7
-35.9
35.7
Change in receivables
24.1
14.7
-71.3
-129
-42.1
111
69.3
Change in payables
-5.51
-15.1
31.1
128
91.8
-128
-32
Cash from operations
486
411
233
1,012
936
1,223
1,680
Cash from investing
-328
-125
-245
-1,124
-1,399
-1,198
-923
Debt issued
0
0
491
199
985
2,075
592
Debt repaid
0
0
-715
-522
Share buybacks
0
0
-18.4
0
0
-7.85
-33.5
Dividends paid
0
0
-27.5
-34.1
-65.1
-115
Cash from financing
-153
-272
105
-7.84
456
207
-245
Net change in cash
4.17
14
93.7
-120
-6.58
232
512
Interest paid
49.4
33.9
35.1
81.9
114
142
273
Income taxes paid
0.03
0.01
0.56
8.16
-1.39
1.85
9.97
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $13.15 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
20.6%
Operating income / revenue.
EBITDA margin
50.7%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
3.5%
Pre-tax income / revenue.
Net margin
1.3%
Net income / revenue.
Operating cash flow margin
45.5%
Cash from operations / revenue.
Effective tax rate
51.7%
Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)
0.5%
Net income / average total assets.
Stock-based pay / revenue
4.0%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
30.2%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
22.1%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
5.4%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
36.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y
5.0%
Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y
-43.7%
Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y
19.5%
EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y
-8.4%
Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 3y
11.2%
Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y
37.4%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y
18.4%
Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y
32.5%
Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
35.8%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
27.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
26.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.94x
Current assets / current liabilities.
Quick ratio
0.23x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.23x
(Cash + short-term investments) / current liabilities.
Debt / assets
43.0%
Total debt / total assets.
Liabilities / assets
57.0%
Total liabilities / total assets.
Net debt
$4.90B
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
2.24x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage
2.50x
Operating income / interest expense.
Working capital
-$64.7M
Current assets - current liabilities.
Efficiency
Metric
Value
How it is calculated
Asset turnover
0.36x
Revenue / average total assets.
Fixed asset turnover
0.41x
Revenue / average property, plant and equipment.
Per share
Metric
Value
How it is calculated
Payout ratio
255.9%
Dividends paid / net income, when net income is positive.
Valuation
Metric
Value
How it is calculated
Market cap
$4.34B
Share price x shares outstanding.
Enterprise value
$9.25B
Market cap + total debt - cash - short-term investments.
P/E
79.4x
Market cap / net income. Only when net income is positive.
P/S
1.01x
Market cap / revenue.
P/OCF
2.22x
Market cap / cash from operations, when positive.
EV/Sales
2.15x
Enterprise value / revenue.
EV/EBIT
10.4x
Enterprise value / operating income, when both are positive.
EV/EBITDA
4.23x
Enterprise value / EBITDA, when both are positive.
Earnings yield
1.3%
Net income / market cap (the inverse of P/E).
Dividend yield
3.2%
Dividends paid over the period / market cap.
Shareholder yield
3.2%
(Dividends paid + share buybacks) / market cap.
What was Crescent Energy Co's revenue in fiscal 2025?
Crescent Energy Co reported revenue of $3.58B for fiscal 2025, 22.1% higher than the year before.
Was Crescent Energy Co profitable in fiscal 2025?
Yes. Net income was $132.9M, a net margin of 3.7%.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.